Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W F Whitmore

Showing results (231-240 of 357) with videos related to

Pageof 36
Sort By:
Cancer Research|October 1, 1986
Cell surface antigens of human bladder tumors: definition of tumor subsets by monoclonal antibodies and correlation with growth characteristicsY Fradet, C Cordon-Cardo, W F Whitmore, et al.
Annals of the New York Academy of Sciences|January 1, 1986
Flow cytometric identification of human bladder cells using a cytokeratin monoclonal antibodyJ L Huffman, P Garin-Chesa, H Gay, et al.
The Journal of Urology|May 1, 1987
Penile cancer: relation of extent of nodal metastasis to survivalV Srinivas, M J Morse, H W Herr, et al.
Clinical Nuclear Medicine|December 1, 1986
Lymphoscintigraphic studies of lymphatic drainage from the testesS D Yeh, M J Morse, R Grando, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1995
Significance of normal serum prostate-specific antigen in the follow-up period after definitive radiation therapy for prostatic cancerM J Zelefsky, S A Leibel, K E Wallner, et al.
Cancer|August 1, 1983
Experimental studies on the radiation-modifying effect of cis-diamminedichloroplatinum II (DDP) in human bladder transitional cell carcinomas grown in nude miceA P Kyriazis, A Yagoda, J G Kereiakes, et al.
Annals of Internal Medicine|July 1, 1981
VAB-6 combination chemotherapy in disseminated cancer of the testisD Vugrin, H W Herr, W F Whitmore, et al.
Urology|March 1, 1985
Gleason grading of prostate cancer: a predictor of survivalP C Sogani, A Israel, P H Lieberman, et al.
The Journal of Urology|December 1, 1993
Impact of transurethral resection on the long-term outcome of patients with prostatic carcinomaM J Zelefsky, W F Whitmore, S A Leibel, et al.
Cancer Treatment Reports|July 1, 1976
Cis-dichlorodiammineplatinum(II) in advanced bladder cancerA Yagoda, R C Watson, J C Gonzalez-Vitale, et al.
Pageof 36

Showing results (231-240 of 357) with videos related to

Sort By:
Pageof 36
Cancer Research|October 1, 1986
Cell surface antigens of human bladder tumors: definition of tumor subsets by monoclonal antibodies and correlation with growth characteristicsY Fradet, C Cordon-Cardo, W F Whitmore, et al.
Annals of the New York Academy of Sciences|January 1, 1986
Flow cytometric identification of human bladder cells using a cytokeratin monoclonal antibodyJ L Huffman, P Garin-Chesa, H Gay, et al.
The Journal of Urology|May 1, 1987
Penile cancer: relation of extent of nodal metastasis to survivalV Srinivas, M J Morse, H W Herr, et al.
Clinical Nuclear Medicine|December 1, 1986
Lymphoscintigraphic studies of lymphatic drainage from the testesS D Yeh, M J Morse, R Grando, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1995
Significance of normal serum prostate-specific antigen in the follow-up period after definitive radiation therapy for prostatic cancerM J Zelefsky, S A Leibel, K E Wallner, et al.
Cancer|August 1, 1983
Experimental studies on the radiation-modifying effect of cis-diamminedichloroplatinum II (DDP) in human bladder transitional cell carcinomas grown in nude miceA P Kyriazis, A Yagoda, J G Kereiakes, et al.
Annals of Internal Medicine|July 1, 1981
VAB-6 combination chemotherapy in disseminated cancer of the testisD Vugrin, H W Herr, W F Whitmore, et al.
Urology|March 1, 1985
Gleason grading of prostate cancer: a predictor of survivalP C Sogani, A Israel, P H Lieberman, et al.
The Journal of Urology|December 1, 1993
Impact of transurethral resection on the long-term outcome of patients with prostatic carcinomaM J Zelefsky, W F Whitmore, S A Leibel, et al.
Cancer Treatment Reports|July 1, 1976
Cis-dichlorodiammineplatinum(II) in advanced bladder cancerA Yagoda, R C Watson, J C Gonzalez-Vitale, et al.
Pageof 36